noven pharmaceuticals inc

Hi Tech Pharmacal Co. Inc. (Nasdaq: HITK) 35.5% HIGHER; reports Q4 EPS of $0.45, versus the consensus of $0.20 (one analyst) and $0.02 last year.

Revenues rose 83% to $38.3 million versus the consensus of $29.2 million. Sinclair Broadcast Group (Nasdaq: SBGI) 31.5% LOWER; continuing lower today following a 21% slide yesterday.

• Noven Pharmaceuticals, Inc. (NASDAQ: NOVN) and Hisamitsu Pharmaceutical Co., Inc. have entered into a definitive merger agreement pursuant to which Hisamitsu has proposed to acquire Noven for total cash consideration of approximately $428 million, or $16.50 per share, in an all-cash tender offer for 100% of the outstanding shares of Noven.
  
  The offer price represents a 22% premium to the closing price of Noven's common stock on July 13, 2009, and a 43% premium to Noven's average closing price for the preceding 90 days.

Noven Pharmaceuticals, Inc. (NASDAQ: NOVN) 22.4% HIGHER; and Hisamitsu Pharmaceutical Co., Inc. have entered into a definitive merger agreement pursuant to which Hisamitsu has proposed to acquire Noven for total cash consideration of approximately $428 million, or $16.50 per share, in an all-cash tender offer for 100% of the outstanding shares of Noven. Here is the full report.

Health Net, Inc.